Hjem › Post-COVID-tilstander (lang-COVID) › Illinois › Chicago
Kliniske studier for Post-COVID-tilstander (lang-COVID) i Chicago, IL
11 studier for Post-COVID-tilstander (lang-COVID) søker deltakere på steder i og rundt Chicago (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
RekruttererFase 3
- Rush University Medical Center ( Site 3748), Chicago
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RekruttererFase 3
- Northwestern Memorial Hospital, Chicago
- Northwestern University Feinberg School of Medicine, Chicago
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
RekruttererFase 3
- Illinois Research Network (ILLInet), University of Illinois Chicago, Chicago
Dime La VerDAD: Verify, Debunk, and Disseminate
RekruttererFrivillige helsepersonell ønskes velkommen
- University of Chicago, Chicago
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
RekruttererFase 3
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Cognitive-Sensorimotor Function in Long-COVID
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Jesse Brown VA Medical Center, Chicago, IL, Chicago
Dysbiosis & Long COVID
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- The University of Chicago, Chicago
A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection
RekruttererFase 4Frivillige helsepersonell ønskes velkommen
- University of Chicago, Chicago
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
RekruttererFase 3
- University of Chicago Medical Center, Chicago
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
RekruttererFase 3
- University of Illinois Health, Chicago
Convalescent Plasma as a Possible Treatment for COVID-19
RekruttererFase 2
- University of Illinois at Chicago, Chicago
Post-COVID-tilstander (lang-COVID)-studier i andre byer
- New York City, NY15 studier
- Houston, TX13 studier
- Boston, MA13 studier
- Baltimore, MD12 studier
- Washington, DC10 studier
- San Francisco, CA8 studier
- Durham, NC8 studier
- Atlanta, GA8 studier
- San Diego, CA7 studier
- Los Angeles, CA6 studier
- Pittsburgh, PA6 studier
- Hialeah, FL6 studier
Andre studier i Chicago
- Ikke-småcellet lungekreft61 studier
- Brystkreft59 studier
- Kreft (alle typer)51 studier
- Metastatisk kreft45 studier
- Prostatakreft45 studier
- Lungekreft41 studier
- Fedme41 studier
- Eggstokkreft36 studier
- Kolorektal kreft34 studier
- Slag34 studier
- Hjertesvikt31 studier
- Overvekt29 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.